Valacyclovir
NDC 87063-349, Valacyclovir, tablet, from ASCLEMED USA INC..
- Product NDC
- 87063-349
- Status
- Listed
- Labeler
- ASCLEMED USA INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209553
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87063-349 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VALACYCLOVIR HYDROCHLORIDE500 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87063-349-02 | 87063034902 | 30 TABLET in 1 BOTTLE (87063-349-02) |
| 87063-349-04 | 87063034904 | 4 TABLET in 1 BOTTLE (87063-349-04) |
| 87063-349-06 | 87063034906 | 6 TABLET in 1 BOTTLE (87063-349-06) |
| 87063-349-07 | 87063034907 | 7 TABLET in 1 BOTTLE (87063-349-07) |
| 87063-349-10 | 87063034910 | 10 TABLET in 1 BOTTLE (87063-349-10) |
| 87063-349-14 | 87063034914 | 14 TABLET in 1 BOTTLE (87063-349-14) |
| 87063-349-15 | 87063034915 | 15 TABLET in 1 BOTTLE (87063-349-15) |
| 87063-349-20 | 87063034920 | 20 TABLET in 1 BOTTLE (87063-349-20) |
| 87063-349-21 | 87063034921 | 21 TABLET in 1 BOTTLE (87063-349-21) |
| 87063-349-30 | 87063034930 | 30 TABLET in 1 BOTTLE (87063-349-30) |
| 87063-349-60 | 87063034960 | 60 TABLET in 1 BOTTLE (87063-349-60) |
| 87063-349-90 | 87063034990 | 90 TABLET in 1 BOTTLE (87063-349-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/8d367c6f-0855-487a-b867-4b493382ef79
Use it
Look up 87063-349 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87063-349 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87063-349. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.